Biotech Values

[steveporsche]

MNTA- Executive Option and Restricted Stock Grants:

http://xml.10kwizard.com/filing_raw.php?repo=tenk&ipage=7442748

On February 22, 2011, the Compensation Committee of the Board of Directors of Momenta Pharmaceuticals, Inc., a Delaware corporation (the “Company”), approved the following grants of options to purchase shares of the Company’s common stock, $0.0001 par value per share (the “Common Stock”), and awards of restricted Common Stock relating to performance during the fiscal year ended December 31, 2010 for the executive officers of the Company listed below:


Stock Options
Restricted Stock


Craig A. Wheeler

100,000
75,000


Richard P. Shea

23,178
9,271


James Roach

23,178
9,271


John E. Bishop

25,495
10,198

The stock option grants set forth above were made under the Company’s 2004 Stock Incentive Plan, as amended (the “2004 Stock Plan”), under the following terms: (i) an exercise price equal to the last reported sale price of the Common Stock on the date of grant, or $13.26 per share, (ii) a ten year duration and (iii) vesting quarterly over the four-year period following the date of grant, provided that the optionee has a continuous relationship with the Company. The shares of restricted Common Stock set forth above were also awarded under the 2004 Stock Plan. Twenty-five percent of the shares of restricted Common Stock subject to such awards shall vest on February 22, 2012 and an additional 6.25% of the shares of restricted Common Stock shall vest at the end of each three-month period thereafter. The Company’s form of Incentive Stock Option Agreement was filed as Exhibit 10.1 to the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2004 and is incorporated herein by reference. The Company’s form of Restricted Stock Agreement was filed as Exhibit 10.2 to the Company’s Current Report on Form 8-K filed on February 28, 2008 and is incorporated herein by reference.